Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study

Autor: Yu, Yongfeng, Guo, Qisen, Zhang, Yongchang, Fang, Jian, Zhong, Diansheng, Liu, Baogang, Pan, Pinhua, Lv, Dongqing, Wu, Lin, Zhao, Yanqiu, Li, Juan, Liu, Zhihua, Liu, Chunling, Su, Haichuan, Fan, Yun, Zhang, Tongmei, Liu, Anwen, Jin, Bo, Wang, Ye, Zhou, Jianying, Zhang, Zhihong, Ran, Fengming, Song, Xia, Wang, Mengzhao, Zhang, Xiaodong, Ma, Rui, Song, Zizheng, Li, Xingya, Cheng, Ying, Wang, Changli, Han, Liang, Shi, Jianhua, Yu, Zhuang, Chen, Yuan, Huang, Jianan, Min, Xuhong, Wang, Limin, Lu, Kaihua, Yang, Minglei, Wang, Pingli, Dong, Xiaorong, Yu, Guohua, Wang, Buhai, Chang, Jianhua, Duan, Jianchun, Cang, Shundong, Song, Quanyi, Yu, Jie, Fan, Songhua, Wang, Linfang, Ren, Yongxin, Luo, Xian, Shi, Michael, Su, Weiguo, Lu, Shun
Zdroj: In The Lancet Respiratory Medicine December 2024 12(12):958-966
Databáze: ScienceDirect